In the current research, we documented the identification as well as the characterization of a brand new atypical opioid receptor with unique damaging regulatory properties in the direction of opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, https://woodym950rjy6.techionblog.com/profile